semaglutide off fda shortage list crackdown on off-brand Ozempic products set to take effect, threatening supply and access for many FDA reconsidering its decision to

Daily activity and step tracking to set goals and encourage a healthier lifestyle

[20] Chivapat S, Sincharoenpokai P, Saktiyasuthorn N, Shuaprom A, thongsrirak P, Sakpetch A, et al

Studies show that patients who are obese or overweight using injectable GLP-1 agonist medications for weight loss, combined with diet and exercise, achieve weight loss of approximately 6% of their body weight at 4 months, 9% at 6 months, and 13% at 12 months

It is prescribed as an adjunct to a reduced calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index (BMI) that is considered outside a healthy range

What are the common side effects

Baetu, Irina, et al